Aditxt (ADTX) Interest & Investment Income (2020 - 2026)
Aditxt (ADTX) recorded quarterly Interest & Investment Income of $280.0 in Q1 2026, up 100.45% quarter-over-quarter from -$62306.0 in Q4 2025, and down 2.78% on a YoY basis from $288.0 in Q1 2025.
Aditxt (ADTX) Interest & Investment Income (2020 - 2026) Analysis & Trends
Aditxt's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $280.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 2.78% year-over-year to $280.0; the TTM figure through Mar 2026 stood at $200171.0 (up 14564.54% YoY), while the FY2025 annual figure was $200179.0, up 13667.47% from the prior year.
- Interest & Investment Income was $280.0 for Q1 2026 at Aditxt, up from -$62306.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $183631.0 in Q3 2025 to a low of -$62306.0 in Q4 2025.
- Historically, Interest & Investment Income has averaged $15848.6 across 5 years, with a median of $378.0 in 2024.
- Biggest YoY gain for Interest & Investment Income was 48738.03% in 2025; the steepest drop was 19389.78% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $27217.0 in 2022, then sank by 98.6% to $382.0 in 2023, then dropped by 15.45% to $323.0 in 2024, then sank by 19389.78% to -$62306.0 in 2025, then surged by 100.45% to $280.0 in 2026.
- The last three Interest & Investment Income figures came in at $280.0 (Q1 2026), -$62306.0 (Q4 2025), and $183631.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 280.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 280.00 |
| Dec 31, 2025 | -62,306.00 |
| Sep 30, 2025 | 183,631.00 |
| Jun 30, 2025 | 78,566.00 |
| Mar 31, 2025 | 288.00 |
| Dec 31, 2024 | 323.00 |
| Sep 30, 2024 | 376.00 |
| Jun 30, 2024 | 378.00 |
| Mar 31, 2024 | 377.00 |
| Dec 31, 2023 | 382.00 |
| Sep 30, 2023 | 367.00 |
| Jun 30, 2023 | 343.00 |
| Mar 31, 2023 | 9,074.00 |
| Dec 31, 2022 | 27,217.00 |
| Sep 30, 2022 | 10,084.00 |
| Jun 30, 2022 | 6,007.00 |
| Mar 31, 2022 | 14,040.00 |
| Dec 31, 2021 | -40,166.00 |
| Sep 30, 2021 | 42,838.00 |
| Jun 30, 2021 | 180.00 |